Published 2014
| Version v1.0.0
Journal Article
Open
Treatment of ADHD: Guanfacine Extended Release in ADHD
Creators
Abstract
Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects.Files
PNB-2014-28-8s-8.pdf
Files
(101.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0f530671f9f40c990770e4f0bd2aeed8
|
101.3 kB | Preview Download |
Additional details
Identifiers
- Other
- PNB-2014-28-8s-8
Dates
- Created
-
2014When the item was originally created.